Additional information
| Dosage | 20 mg / 0.4 ml, 40 mg / 0.8 ml |
|---|---|
| Package | 2 injector, 4 injector, 8 injector |
| Active Ingredient | Adalimumab |
This Clinical Guidance (“Guidance”) is provided for informational and educational purposes only. It is intended to offer physicians guidance regarding best practices in caring for and treating patients infected by COVID-19. Adherence to any recommendations included in this Guidance will not ensure successful treatment in every situation. Furthermore, the recommendations contained in this Guidance should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care.
